However, we are only about 65% enrolled. That comes to 260 total patients for a trial size of 400.
Trial size is 550 patients so that means at least 357 patients are enrolled. If the trial enrolls 400 patients with a CRP<150mg/L, then they will stop enrollment. So 550 total patients or 400 patients with a CRP<150mg/L, whichever comes first.